Skip to Main Content

Paper Details

CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses.
J Immunol
53
2015
(, (+)CD16(++) monocytes, CD14, CD14(, CD14(+, CD14(++, CD14(++), CD14(++)CD16(+) cells, CD14(++)CD16(+) monocytes, CD14(++)CD16(+) subset, CD14+, CD14++CD16+ Monocytes, CD16, CD16+, CD4, CD4(+, CD4(+), CD4(+) T cell, Human, Human peripheral monocytes, IL-10, IL-17, T Cell, T regulatory cell, Th1, Th1 phenotype, autoimmune disease, autoimmune uveitis, circulating monocytes, classical CD14(++)CD16(-), intermediate, intermediate CD14(, intermediate CD14(++)CD16(+) cells, intermediate CD14(++)CD16(+) monocytes, memory CD4(+) T, memory CD4(+) T cell, monocyte subsets, naive CD4(+) T cell, nonclassical CD14, patients
Author NameAffiliation
Hatice Nida SenNational Eye Institute, National Institutes of Health
Han SiNational Eye Institute, National Institutes of Health
Han SiNational Eye Institute, National Institutes of Health
Robert B NussenblattNational Eye Institute, National Institutes of Health
  • 1 - 4

Datasets

Release 1.2